Delcath Systems (FRA:DV3R) Days Payable : 474.85 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Delcath Systems Days Payable?

Delcath Systems's average Accounts Payable for the three months ended in Dec. 2023 was €0.82 Mil. Delcath Systems's Cost of Goods Sold for the three months ended in Dec. 2023 was €0.16 Mil. Hence, Delcath Systems's Days Payable for the three months ended in Dec. 2023 was 474.85.

The historical rank and industry rank for Delcath Systems's Days Payable or its related term are showing as below:

FRA:DV3R' s Days Payable Range Over the Past 10 Years
Min: 291.34 Med: 852.47 Max: 3108.85
Current: 825.07

During the past 13 years, Delcath Systems's highest Days Payable was 3108.85. The lowest was 291.34. And the median was 852.47.

FRA:DV3R's Days Payable is ranked better than
94.39% of 785 companies
in the Medical Devices & Instruments industry
Industry Median: 73.19 vs FRA:DV3R: 825.07

Delcath Systems's Days Payable declined from Dec. 2022 (929.41) to Dec. 2023 (474.85). It may suggest that Delcath Systems accelerated paying its suppliers.

Delcath Systems Days Payable Historical Data

The historical data trend for Delcath Systems's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delcath Systems Days Payable Chart

Delcath Systems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

3,063.57

1,921.45

621.54

695.64

886.83

Delcath Systems Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															929.41	1,126.59	1,037.23	583.27	474.85

Competitive Comparison of Delcath Systems's Days Payable

For the Medical Devices subindustry, Delcath Systems's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delcath Systems's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's Days Payable distribution charts can be found below:

* The bar in red indicates where Delcath Systems's Days Payable falls into.

Delcath Systems Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Delcath Systems's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.905	+	0.928)	/	2 )	/	0.583	*	365
=	1.4165					/	0.583	*	365
=	886.83

Delcath Systems's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.706	+	0.928)	/	2 )	/	0.157	*	365 / 4
=	0.817					/	0.157	*	365 / 4
=	474.85

Delcath Systems Days Payable Related Terms

Thank you for viewing the detailed overview of Delcath Systems's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems (FRA:DV3R) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (FRA:DV3R) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

DCTH:USA

Address

1633 Broadway, Suite 22C, New York, NY, USA, 10019

Website

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Delcath Systems (FRA:DV3R) Headlines

No Headlines